Hyderabad: The country’s first potential COVID-19 vaccine has received the green light from Drug Controller General of India (DCGI) for Phase I and II human clinical trials.
The trials will begin across the country in July.
The vaccine, COVAXIN, has been developed by Hyderabad-based Bharat Biotech, in association with Indian Council for Medical Research (ICMR). It is an inactivated vaccine created from a strain of the infectious SARS-CoV-2 virus.
The vaccine has shown promising results in preclinical studies, demonstrating extensive safety and effective immune responses.
Globally, AstraZeneca’s vaccine followed by Moderna’s are in the lead with the latter scheduled to conduct Phase III trials from mid-July.
AstraZeneca, which has developed the vaccine with the help of researchers at the University of Oxford, has started large-scale mid-stage human trials.
China too has developed a vaccine in association with CanSino Biologics, which shows promising results in early clinical trials.
New Delhi: After a period of strained relations, Prime Minister Narendra Modi underscored the importance…
Bhubaneswar: Aspirants for the posts of Amin and RI staged a demonstration in Bhubaneswar on…
Bhubaneswar: Rain coupled with thunderstorm, gusty wind and lightning is likely to lash at least…
Nuapada: A youth sustained bullet injuries after two unidentified miscreants opened fire at him in…
Kolkata: This Durga Puja, devotees will witness the spiritual grandeur of Puri’s Jagannath Temple at…
Mumbai: Dismissing news reports that he was admitted to the Intensive Care Unit (ICU) of…
Bhubaneswar: Odisha Vigilance officials on Monday apprehended Jitendra Kumar Padhy, Executive Engineer (EE) in Tel…
Bhubaneswar: Three players from Odisha have been selected in Indian Junior Men’s Hockey Team heading…